Literature DB >> 20503216

Interaction of metal complexes with G-quadruplex DNA.

Savvas N Georgiades1, Nurul H Abd Karim, Kogularamanan Suntharalingam, Ramon Vilar.   

Abstract

Guanine-rich sequences of DNA can assemble into tetrastranded structures known as G-quadruplexes. It has been suggested that these secondary DNA structures could be involved in the regulation of several key biological processes. In the human genome, guanine-rich sequences with the potential to form G-quadruplexes exist in the telomere as well as in promoter regions of certain oncogenes. The identification of these sequences as novel targets for the development of anticancer drugs has sparked great interest in the design of molecules that can interact with quadruplex DNA. While most reported quadruplex DNA binders are based on purely organic templates, numerous metal complexes have more recently been shown to interact effectively with this DNA secondary structure. This Review provides an overview of the important roles that metal complexes can play as quadruplex DNA binding molecules, highlighting the unique properties metals can confer to these molecules.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20503216     DOI: 10.1002/anie.200906363

Source DB:  PubMed          Journal:  Angew Chem Int Ed Engl        ISSN: 1433-7851            Impact factor:   15.336


  57 in total

Review 1.  G-quadruplexes-novel mediators of gene function.

Authors:  Wenhua Zhou; Nigel J Brand; Liming Ying
Journal:  J Cardiovasc Transl Res       Date:  2011-02-08       Impact factor: 4.132

2.  Copper(ii) l/d-valine-(1,10-phen) complexes target human telomeric G-quadruplex motifs and promote site-specific DNA cleavage and cellular cytotoxicity.

Authors:  Farukh Arjmand; Surbhi Sharma; Sabiha Parveen; Loic Toupet; Zhen Yu; James Allan Cowan
Journal:  Dalton Trans       Date:  2020-07-21       Impact factor: 4.390

3.  Exploiting σ-hole interaction to design small uncharged ligand molecules to stabilize G-quadruplex-DNA: a computational study.

Authors:  Mrinal Kanti Si; Anusuya Saha; Bishwajit Ganguly
Journal:  J Mol Model       Date:  2020-02-01       Impact factor: 1.810

4.  Interactions of a platinum-modified perylene derivative with the human telomeric G-quadruplex.

Authors:  Lu Rao; Joshua D Dworkin; William E Nell; Ulrich Bierbach
Journal:  J Phys Chem B       Date:  2011-10-28       Impact factor: 2.991

5.  Conformation-sensitive nucleoside analogues as topology-specific fluorescence turn-on probes for DNA and RNA G-quadruplexes.

Authors:  Arun A Tanpure; Seergazhi G Srivatsan
Journal:  Nucleic Acids Res       Date:  2015-07-21       Impact factor: 16.971

6.  Combining a Ru(II) "Building Block" and Rapid Screening Approach to Identify DNA Structure-Selective "Light Switch" Compounds.

Authors:  Erin Wachter; Diego Moyá; Edith C Glazer
Journal:  ACS Comb Sci       Date:  2016-12-28       Impact factor: 3.784

7.  Chiral metallohelices enantioselectively target hybrid human telomeric G-quadruplex DNA.

Authors:  Andong Zhao; Suzanne E Howson; Chuanqi Zhao; Jinsong Ren; Peter Scott; Chunyu Wang; Xiaogang Qu
Journal:  Nucleic Acids Res       Date:  2017-05-19       Impact factor: 16.971

8.  Study of the synthesis, antiproliferative properties, and interaction with DNA and polynucleotides of cisplatin-like Pt(II) complexes containing carcinogenic polyaromatic amines.

Authors:  Elisabetta Gabano; Sofia Gama; Filipa Mendes; Marzia B Gariboldi; Elena Monti; Sophie Bombard; Sabrina Bianco; Mauro Ravera
Journal:  J Biol Inorg Chem       Date:  2013-07-20       Impact factor: 3.358

9.  A Nitroxide-Tagged Platinum(II) Complex Enables the Identification of DNA G-Quadruplex Binding Mode.

Authors:  Cui-Xia Xu; Xiaojun Zhang; Yi-Wei Zhou; Hanqiang Wang; Qian Cao; Yong Shen; Liang-Nian Ji; Zong-Wan Mao; Peter Z Qin
Journal:  Chemistry       Date:  2016-02-04       Impact factor: 5.236

10.  Keeping those telomeres short! an innovative intratumoral long-term drug delivery system.

Authors:  B H Laster; C Isaacson; E Perets; M Msamra; E Priel; J Kalef-Ezra; J Kost
Journal:  J Cancer Res Clin Oncol       Date:  2014-07-30       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.